Feedback / Questions
vesemnogene lantuparvovec (AAV-hSMN1) - Lantu Biopharma
http://clinicaltrials.gov/ct2/show/NCT06288230
Oct 9, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next